Systemic contraindications for laser vision correction surgery

IF 0.1 Q4 PEDIATRICS
Maciej Juda, J. Wierzbowska
{"title":"Systemic contraindications for laser vision correction surgery","authors":"Maciej Juda, J. Wierzbowska","doi":"10.15557/pimr.2022.0049","DOIUrl":null,"url":null,"abstract":"Introduction: Laser refractive surgery corrects refractive errors by changing the shape of the anterior surface of the cornea and its refractive power by using a laser. Patients with refractive errors and systemic comorbidities pose a challenge for refractive surgeons. According to the guidelines of ophthalmological societies, the coexistence of autoimmune connective tissue diseases or hormonal disorders, some pharmacotherapies, pregnancy and lactation are contraindications for refractive procedures. These recommendations have been formulated on the basis of case reports or recommendations coming from other ophthalmic surgeries. Aim: The aim of the study was to summarise the current literature data on systemic contraindications for laser vision correction. Materials and methods: The literature review included the PubMed database. In the search for relevant articles, the following keywords were used: “refractive surgery”, “contraindications”, “LASIK”, “PRK”, “laser in situ keratomileusis”, “photorefractive keratectomy”. The references of articles that met the criteria were also analysed. Discussion: The main reason for considering some systemic conditions and pharmacotherapy as exclusion criteria for refractive surgery was the concern of an increased risk of postoperative eye inflammation, unpredictable healing and corneal remodelling, as well as a severe dry eye syndrome. In recent decades, a number of articles have been published supporting the safety profile of refractive procedures in patients with inactive autoimmune diseases, well-controlled diabetes or undergoing specific pharmacotherapy. These publications were based on either retrospective studies or case series, with short-term follow-up and their results should be interpreted with caution. Conclusions: Active or uncontrolled autoimmune diseases, pregnancy and lactation are absolute contraindications for laser vision correction. The decision to perform refractive surgery in patients with inactive and well- controlled systemic diseases or risk factors should be made individually and carefully by an experienced surgeon.","PeriodicalId":42380,"journal":{"name":"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine","volume":" ","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15557/pimr.2022.0049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Laser refractive surgery corrects refractive errors by changing the shape of the anterior surface of the cornea and its refractive power by using a laser. Patients with refractive errors and systemic comorbidities pose a challenge for refractive surgeons. According to the guidelines of ophthalmological societies, the coexistence of autoimmune connective tissue diseases or hormonal disorders, some pharmacotherapies, pregnancy and lactation are contraindications for refractive procedures. These recommendations have been formulated on the basis of case reports or recommendations coming from other ophthalmic surgeries. Aim: The aim of the study was to summarise the current literature data on systemic contraindications for laser vision correction. Materials and methods: The literature review included the PubMed database. In the search for relevant articles, the following keywords were used: “refractive surgery”, “contraindications”, “LASIK”, “PRK”, “laser in situ keratomileusis”, “photorefractive keratectomy”. The references of articles that met the criteria were also analysed. Discussion: The main reason for considering some systemic conditions and pharmacotherapy as exclusion criteria for refractive surgery was the concern of an increased risk of postoperative eye inflammation, unpredictable healing and corneal remodelling, as well as a severe dry eye syndrome. In recent decades, a number of articles have been published supporting the safety profile of refractive procedures in patients with inactive autoimmune diseases, well-controlled diabetes or undergoing specific pharmacotherapy. These publications were based on either retrospective studies or case series, with short-term follow-up and their results should be interpreted with caution. Conclusions: Active or uncontrolled autoimmune diseases, pregnancy and lactation are absolute contraindications for laser vision correction. The decision to perform refractive surgery in patients with inactive and well- controlled systemic diseases or risk factors should be made individually and carefully by an experienced surgeon.
激光视力矫正手术的全身禁忌症
简介:激光屈光手术是利用激光改变角膜前表面的形状和屈光能力来矫正屈光不正的手术。屈光不正和全身合并症患者对屈光外科医生提出了挑战。根据眼科学会的指南,自身免疫性结缔组织疾病或激素紊乱、某些药物治疗、妊娠和哺乳期并存是屈光手术的禁忌症。这些建议是根据病例报告或其他眼科手术的建议制定的。目的:本研究的目的是总结目前关于激光视力矫正的系统性禁忌症的文献资料。材料和方法:文献综述包括PubMed数据库。在检索相关文章时,使用的关键词有:“屈光手术”、“禁忌症”、“LASIK”、“PRK”、“激光原位角膜磨除术”、“光屈光性角膜切除术”。对符合标准的文章的参考文献也进行了分析。讨论:考虑一些全身情况和药物治疗作为屈光手术的排除标准的主要原因是担心术后眼睛炎症、不可预测的愈合和角膜重塑以及严重干眼综合征的风险增加。近几十年来,已经发表了许多文章,支持对非活动性自身免疫性疾病、控制良好的糖尿病或正在接受特定药物治疗的患者进行屈光手术的安全性。这些出版物是基于回顾性研究或病例系列,并进行了短期随访,其结果应谨慎解释。结论:活动性或未控制的自身免疫性疾病、妊娠和哺乳期是激光视力矫正的绝对禁忌症。对于不活跃且控制良好的全身性疾病或危险因素的患者,应由经验丰富的外科医生单独和仔细地决定是否进行屈光手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
33
审稿时长
20 weeks
期刊介绍: PEDIATRIA I MEDYCYNA RODZINNA is a peer-reviewed scientific journal publishing original articles that constitute significant contributions to the advancements of paediatrics and family medicine. In addition, PEDIATRIA I MEDYCYNA RODZINNA, publishes information from the medical associations, reports and materials from international congresses, letters to the Editor, information on new medical products as well as abstracts and discussions on papers published in other scientific journals, reviews of books and other publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信